Neurovascular Thrombus Management Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore | Includes: Stent Retrievers and Aspiration Catheters

Neurovascular Thrombus Management Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore | Includes: Stent Retrievers and Aspiration Catheters

The global market for neurovascular thrombus management was valued at $1.3 billion in 2022 and is anticipated to grow at a CAGR of 5.9% during the forecast period, reaching $1.9 billion. The complete report suite for the global neurovascular thrombus management market covers stent retrievers and aspiration catheters.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends

COVID-19 Impact Analysis

Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL NEUROVASCULAR THROMBUS MANAGEMENT MARKET INSIGHTS

One of the primary drivers of the global neurovascular thrombus management market is the continuous improvement of technology. The significant advancements in mechanical thrombus management devices have led to better clinical outcomes, which in turn is driving an increase in procedural growth. However, one of the main market limiters is the narrow time window for deploying mechanical thrombectomy treatment.

GLOBAL NEUROVASCULAR THROMBUS MANAGEMENT MARKET SHARE INSIGHTS

Within the global market for neurovascular thrombus management, there are three key market players – Medtronic, Stryker, and Penumbra. In 2022, Medtronic was the leader in the global neurovascular thrombus management market. The company competes with its SolitaireTMFlow Restoration Device.

MARKET SEGMENTATION SUMMARY

Global Stent Retrievers Market
Global Aspiration Catheter Market

RESEARCH SCOPE SUMMARY

Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage– iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing– When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.